Physician profile
Clinton Young
NPI 1346277449
$3,221.35
in general payments reported to CMS, 2019-2025
12 companies · $1,110 in 2025
The $1,110 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.47 · 2023: $1,055 · 2024: $1,043 · 2025: $1,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,207.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,443.88 | 2023-2025 | Biktarvy, Epclusa |
| Viiv Healthcare Company | $966.03 | 2023-2025 | Cabenuva, Rukobia, Apretude |
| Merck Sharp & Dohme LLC | $384.80 | 2023-2025 | Pifeltro, Delstrigo, Capvaxive |
| Alkermes, INC. | $138.57 | 2023-2025 | Vivitrol, Aristada, Vivitrol |
| Emd Serono, INC. | $76.14 | 2024-2025 | |
| Theratechnologies INC. | $66.16 | 2025 | Egrifta, Trogarzo |
| Lilly USA, LLC | $54.52 | 2025 | Zepbound |
| Abbvie INC. | $22.04 | 2025 | |
| Braeburn INC. | $20.45 | 2025 | Brixadi |
| Janssen Biotech, INC. | $17.87 | 2023 | Symtuza |
| Janssen Pharmaceuticals, INC | $17.42 | 2025 | Invega Sustenna, Invega Trinza |
| Baxter Healthcare | $13.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.